The most recent study showed that CHIT1 levels correlated with the level of fibrosis and inflammation in liver sections from MASH patients (22), highlighting CHIT1 as a target in MASH. The gene discussed is CHIT1; the disease is metabolic dysfunction-associated steatohepatitis.